FDA Recalls Common Heart Drug Over Cancer Concerns
Impurity in drug’s active ingredient has been linked to cancer.
By Fran Kritz
Medically Reviewed by Michael Cutler, DO, PhD
July 19, 2018
Three U.S. companies have voluntarily recalled drugs that contain the active ingredient valsartan, a generic drug used to treat heart failure and high blood pressure.
The drugs are being recalled because an impurity, N-nitrosodimethylamine (NDMA), which has been linked to cancer, was found in the medications. All three companies recalling the drugs buy valsartan from the same Chinese manufacturer, Zhejiang Huahai Pharmaceutical Co. Ltd.
https://www.everydayhealth.com/heart-failure/fda-recalls-common-heart-drug-over-cancer-concerns/
